Stereotactic body radiation therapy (SBRT) is both safe and effective for men with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Intermediate-risk transcatheter aortic valve replacement (TAVR) patients see fewer strokes, deaths and encephalopathies than those who undergo surgical aortic valve replacement (SAVR), researchers reported in the Oct. 30 edition of the Journal of the American College of Cardiology.

Patients evaluated for chest pain in busier emergency departments experience lower rates of death or hospitalization for acute coronary syndrome (ACS) at both 30 days and one year, according to a study published Oct. 23 in Circulation: Cardiovascular Quality and Outcomes.

Medtronic co-founder Earl Bakken, who invented the world’s first wearable, battery-powered pacemaker, died on Oct. 21 in his Hawaii home, the company announced. He was 94.

A team of Chicago researchers has identified four genetic variants specific to people of African ancestry which may help explain their increased incidence of warfarin-associated bleeding events.

Managing their high blood pressure is the best way patients with diabetes can avoid hypertensive emergencies, according to research published in Clinical and Experimental Hypertension this fall.

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

A small-scale pilot study has linked omega-3 fatty acid supplementation to improved social function and reduced cognitive depression in patients with combined chronic heart failure (CHF) and major depressive disorder.